Cellular transplants as sources for therapeutic agents (Q34003138)

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Non-viral gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Plasmid DNA adsorbed to pH-sensitive liposomes efficiently transforms the target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cationic liposome-mediated transfection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polyamidoamine cascade polymers mediate efficient transfection of cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Electroporation for the efficient transfection of mammalian cells with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Nonviral strategies for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Adenovirus enhancement of transferrin-polylysine-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy - promises, problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Approaches to the management of postprandial hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Sustained proliferation of PDX-1+ cells derived from human islets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Expansion of functional adult porcine islet cells in vitro using purified laminin 5

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transplantation of neural tissue in polymer capsules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Drug delivery to the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Review: Tissue engineering in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Biomaterials in tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Encapsulated cell technology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Encapsulated cells as therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Recent progress in immunoisolated cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Neural tissue engineering: from polymer to biohybrid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intrastriatal implants of polymer-encapsulated PC12 cells: effects on motor function in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cellular Delivery of NGF Does Not Alter the Expression of β-Amyloid Immunoreactivity in Young or Aged Nonhuman Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer-encapsulated Schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after a fimbria-fornix transection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Treatment of amyotrophic lateral sclerosis using a gene therapy approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Polymer-Encapsulated PC-12 Cells Demonstrate High-Affinity Uptake of Dopamine in Vitro and 18F-DOPA Uptake and Metabolism after Intracerebral Implantation in Nonhuman Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

POLYMER-ENCAPSULATED PC12 CELLS: LONG-TERM SURVIVAL AND ASSOCIATED REDUCTION IN LESION-INDUCED ROTATIONAL BEHAVIOR.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Femoral shaft reconstruction using tissue-engineered growth of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Tissue-engineered nipple reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transplantation of Chondrocytes Utilizing a Polymer-Cell Construct to Produce Tissue-Engineered Cartilage in the Shape of a Human Ear

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Deformation of articular cartilage collagen structure under static and cyclic loading.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Collagen in tissue-engineered cartilage: Types, structure, and crosslinks

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Autogenous tissue-engineered cartilage: evaluation as an implant material

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Chondrogenesis in a cell-polymer-bioreactor system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Creation of viable pulmonary artery autografts through tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

The in vitro construction of a tissue engineered bioprosthetic heart valve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Regenerative signals for tissue-engineered small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Skeletal myogenesis on elastomeric substrates: implications for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Tissue-engineered skeletal muscle organoids for reversible gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A metabolically active human dermal replacement for the treatment of diabetic foot ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In vitro toxicity of various classes of test agents using the neutral red assay on a human three-dimensional physiologic skin model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

De novo reconstitution of a functional mammalian urinary bladder by tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A completely biological tissue-engineered human blood vessel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Stem cells in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Vertebrate neural progenitor cells: subtypes and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Astrocyte precursors in neonatal rat spinal cord cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Isolation, cloning and characterization of a putative type-1 astrocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Purification and characterization of astrocyte precursor cells in the developing rat optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Neuronal stem cells in the brain of adult vertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Isolation of Lineage-Restricted Neuronal Precursors from Multipotent Neuroepithelial Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Glial-Restricted Precursors Are Derived from Multipotent Neuroepithelial Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A tripotential glial precursor cell is present in the developing spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A role for platelet-derived growth factor in normal gliogenesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Growth and fate of PSA-NCAM+ precursors of the postnatal brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cerebral white matter contains PDGF-responsive precursors to O2A cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

The olfactory nerve contains two populations of glia, identified both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In vitro expansion of a multipotent population of human neural progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A proliferative adult human oligodendrocyte progenitor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Xenotransplantation of Transgenic Oligodendrocyte-Lineage Cells into Spinal Cord-Injured Adult Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

"Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Delivery of recombinant gene product to canines with nonautologous microencapsulated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Experiments in a Parkinson's rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Novel therapeutic directions for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Bcl-2: Prolonging Life in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Gene therapy for long-term expression of erythropoietin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral Vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Targeting of an inducible toxic phenotype in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Current status of CF gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts--an alternate approach to somatic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term secretion of therapeutic proteins from genetically modified skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Encapsulation for somatic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900052-1

7 January 2021